Hikma Pharmaceuticals LLC FDA Record
- Latest inspection VAI · Sep 5, 2019
- No warning letters matched by name
Hikma Pharmaceuticals LLC has 0 FDA recalls, 5 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Hikma Pharmaceuticals LLC" is on file.
- Latest recall
- D-0076-2027 · Oct 6, 2026 · filed under Hikma Pharmaceuticals Usa
- Latest inspection
- Sep 5, 2019 · VAI
Newer recall under related name Hikma Pharmaceuticals Usa: Oct 6, 2026, D-0076-2027.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 5 | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Reviewing Hikma Pharmaceuticals LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Hikma Pharmaceuticals LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Sep 5, 2019 | Amman, Jordan | Drugs | Voluntary Action Indicated (VAI) | 3002806351 |
| Jul 27, 2016 | Amman, Jordan | Drugs | Voluntary Action Indicated (VAI) | 3002806351 |
| Jun 25, 2015 | Amman, Jordan | Drugs | Voluntary Action Indicated (VAI) | 3002806351 |
| Apr 12, 2012 | Amman, Jordan | Drugs | No Action Indicated (NAI) | 3002806351 |
| Feb 4, 2010 | Amman, Jordan | Drugs | No Action Indicated (NAI) | 3002806351 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3002806351 | Amman, Jordan | 5 | Sep 5, 2019 |
Hikma Pharmaceuticals LLC and the FDA: common questions
Has Hikma Pharmaceuticals LLC received an FDA warning letter?
No FDA warning letter addressed to the name "Hikma Pharmaceuticals LLC" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Hikma Pharmaceuticals LLC received an FDA Form 483?
FDA has not published a Form 483 for "Hikma Pharmaceuticals LLC" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Hikma Pharmaceuticals LLC?
The most recent FDA inspection on file ended Sep 5, 2019 at Amman, Jordan and was classified VAI. FDA has 5 inspections of Hikma Pharmaceuticals LLC on file.
Need more than this page shows? Ask about Hikma Pharmaceuticals LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.